Bioinformatics analysis and the clinical significance of TP73 in regulating the immune microenvironment and chemosensitivity of endometrial cancer
iCell · 01.11.2024
DOI: 10.71373/ndfq5031 ↗Kurz gefasst
Fachartikel in der Zeitschrift iCell, online erschienen am 01.11.2024. Verfasst von Jia Lu und 6 weiteren Autor:innen.
Abstract (Originalsprache)
TP73 is highly expressed in endometrial cancer and has diagnostic and prognostic value. It may contribute to tumor progression by modulating the immune microenvironment and chemotherapy sensitivity, suggesting its potential as a target for precision therapy in this disease. However, this study is solely based on bioinformatics mining of public databases and has not conducted experimental validation, including in vitro cell experiments, in vivo animal experiments, or clinical sample verification. All the conclusions are predictive results and cannot confirm the actual biological functions of TP73 in regulating the immune microenvironment of endometrial cancer and chemotherapy sensitivity, which is the main limitation of this study.
Zitieren
APA
Lu, J., Yang, T., Ye, J., Chen, Y., Nong, D., Meng, L., & Fan, J. (2024). Bioinformatics analysis and the clinical significance of TP73 in regulating the immune microenvironment and chemosensitivity of endometrial cancer. iCell. https://doi.org/10.71373/ndfq5031
Vancouver
Lu J, Yang T, Ye J, Chen Y, Nong D, Meng L, et al. Bioinformatics analysis and the clinical significance of TP73 in regulating the immune microenvironment and chemosensitivity of endometrial cancer. iCell. 2024. doi:10.71373/ndfq5031
BibTeX
@article{Lu2024,
author = {Lu, Jia and Yang, Tongyan and Ye, Junjie and Chen, Yunyi and Nong, Dejun and Meng, Lingzhang and Fan, Jiangtao},
title = {Bioinformatics analysis and the clinical significance of TP73 in regulating the immune microenvironment and chemosensitivity of endometrial cancer},
journal = {iCell},
year = {2024},
doi = {10.71373/ndfq5031}
}
EUVIMED